• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补充辅酶Q对患有黏液瘤样二尖瓣疾病犬的氧化应激标志物、炎症标志物、淋巴细胞亚群及临床状况的影响

Effects of Coenzyme Q Supplementation on Oxidative Stress Markers, Inflammatory Markers, Lymphocyte Subpopulations, and Clinical Status in Dogs with Myxomatous Mitral Valve Disease.

作者信息

Druzhaeva Natalia, Nemec Svete Alenka, Tavčar-Kalcher Gabrijela, Babič Janja, Ihan Alojz, Pohar Katka, Krapež Uroš, Domanjko Petrič Aleksandra

机构信息

Small Animal Clinic, Veterinary Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.

Institute of Food Safety, Feed and Environment, University of Ljubljana, 1000 Ljubljana, Slovenia.

出版信息

Antioxidants (Basel). 2022 Jul 22;11(8):1427. doi: 10.3390/antiox11081427.

DOI:10.3390/antiox11081427
PMID:35892628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9394267/
Abstract

Scarce data exist on the effects of coenzyme Q (CoQ) supplementation in dogs with myxomatous mitral valve disease (MMVD). The purpose of this study was to investigate the effect of CoQ supplementation on oxidative stress markers (glutathione peroxidase, F2-isoprostanes), markers of inflammation (tumor necrosis factor-α, TNF soluble receptor II, leucocytes, and their subtypes), lymphocyte subpopulations (T helper and cytotoxic T lymphocytes, including activated T lymphocytes, and B lymphocytes), and echocardiographic and clinical parameters in dogs with MMVD. In this randomized, controlled, double-blind, longitudinal study, 43 MMVD dogs in stages ACVIM (American College of Veterinary Internal Medicine classification) B2 and ACVIM C and D (congestive heart failure (CHF)) received water-soluble coenzyme Q (100 mg twice daily) or placebo for 3 months, and 12 non-supplemented healthy dogs served as controls. All parameters were measured before and after supplementation in MMVD dogs and once in healthy dogs. CoQ supplementation had a positive impact on neutrophil percentage, lymphocyte percentage, and lymphocyte concentration in our cohort of dogs with CHF (ACVIM C and D). Conclusion: CoQ as an oral supplement may have benefits in terms of decreasing inflammation in dogs with MMVD and CHF.

摘要

关于辅酶Q(CoQ)补充剂对患有黏液瘤性二尖瓣疾病(MMVD)的犬类的影响,现有数据稀缺。本研究的目的是调查补充CoQ对MMVD犬类氧化应激标志物(谷胱甘肽过氧化物酶、F2-异前列腺素)、炎症标志物(肿瘤坏死因子-α、肿瘤坏死因子可溶性受体II、白细胞及其亚型)、淋巴细胞亚群(辅助性T淋巴细胞和细胞毒性T淋巴细胞,包括活化T淋巴细胞和B淋巴细胞)以及超声心动图和临床参数的影响。在这项随机、对照、双盲、纵向研究中,43只处于美国兽医内科学会(ACVIM)分类B2期以及ACVIM C期和D期(充血性心力衰竭(CHF))的MMVD犬类接受了水溶性辅酶Q(每日两次,每次100毫克)或安慰剂治疗3个月,12只未补充的健康犬类作为对照。在MMVD犬类补充前后以及在健康犬类中各测量一次所有参数。在我们患有CHF(ACVIM C期和D期)的犬类队列中,补充CoQ对中性粒细胞百分比、淋巴细胞百分比和淋巴细胞浓度有积极影响。结论:CoQ作为口服补充剂可能在减轻患有MMVD和CHF的犬类炎症方面有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7b/9394267/69fbd1ced0bd/antioxidants-11-01427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7b/9394267/69fbd1ced0bd/antioxidants-11-01427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7b/9394267/69fbd1ced0bd/antioxidants-11-01427-g001.jpg

相似文献

1
Effects of Coenzyme Q Supplementation on Oxidative Stress Markers, Inflammatory Markers, Lymphocyte Subpopulations, and Clinical Status in Dogs with Myxomatous Mitral Valve Disease.补充辅酶Q对患有黏液瘤样二尖瓣疾病犬的氧化应激标志物、炎症标志物、淋巴细胞亚群及临床状况的影响
Antioxidants (Basel). 2022 Jul 22;11(8):1427. doi: 10.3390/antiox11081427.
2
Randomized, double-blinded, controlled trial of the effects of coenzyme Q supplementation on plasma coenzyme Q concentration in dogs with myxomatous mitral valve disease.随机、双盲、对照试验研究辅酶 Q 补充对黏液样二尖瓣病变犬血浆辅酶 Q 浓度的影响。
Am J Vet Res. 2021 Apr;82(4):280-285. doi: 10.2460/ajvr.82.4.280.
3
Peripheral blood lymphocyte subtypes in dogs with different stages of myxomatous mitral valve disease.不同阶段黏液瘤性二尖瓣疾病犬的外周血淋巴细胞亚群。
J Vet Intern Med. 2021 Sep;35(5):2112-2122. doi: 10.1111/jvim.16207. Epub 2021 Jul 8.
4
Depleted Myocardial Coenzyme Q10 in Cavalier King Charles Spaniels with Congestive Heart Failure Due to Myxomatous Mitral Valve Disease.患有黏液瘤性二尖瓣疾病所致充血性心力衰竭的查理士王小猎犬心肌辅酶Q10水平降低。
Antioxidants (Basel). 2021 Jan 22;10(2):161. doi: 10.3390/antiox10020161.
5
Neutrophil-to-lymphocyte ratio is increased in dogs with acute congestive heart failure secondary to myxomatous mitral valve disease compared to both dogs with heart murmurs and healthy controls.与患有心脏杂音的犬只和健康对照相比,继发于黏液瘤性二尖瓣疾病的急性充血性心力衰竭犬的中性粒细胞与淋巴细胞比值升高。
J Am Vet Med Assoc. 2023 Jul 5;261(11):1-8. doi: 10.2460/javma.23.03.0131. Print 2023 Nov 1.
6
Evaluation of antioxidant status and lipid peroxidation in dogs with myxomatous mitral valve degeneration stage B1.B1期黏液瘤样二尖瓣退化犬抗氧化状态和脂质过氧化的评估。
Front Vet Sci. 2023 Sep 6;10:1203480. doi: 10.3389/fvets.2023.1203480. eCollection 2023.
7
Inflammatory and immune variables as predictors of survival in dogs with myxomatous mitral valve disease.炎症和免疫变量作为预测黏液样二尖瓣疾病犬生存的指标。
BMC Vet Res. 2024 Sep 28;20(1):431. doi: 10.1186/s12917-024-04266-7.
8
Severity of myxomatous mitral valve disease in dogs may be predicted using neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratio.犬黏液瘤性二尖瓣疾病的严重程度可通过中性粒细胞与淋巴细胞比值和单核细胞与淋巴细胞比值预测。
Am J Vet Res. 2023 Apr 10;84(6). doi: 10.2460/ajvr.23.01.0012. Print 2023 Jun 1.
9
Inflammation and its association with oxidative stress in dogs with heart failure.心力衰竭犬的炎症及其与氧化应激的关系。
BMC Vet Res. 2021 Apr 26;17(1):176. doi: 10.1186/s12917-021-02878-x.
10
Pharmacokinetics of Repeated Oral Dosing with Coenzyme Q10 in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease.辅酶Q10对患有黏液瘤性二尖瓣疾病的查理士王小猎犬重复口服给药的药代动力学
Antioxidants (Basel). 2020 Sep 4;9(9):827. doi: 10.3390/antiox9090827.

引用本文的文献

1
Evaluation of antioxidant status and lipid peroxidation in dogs with myxomatous mitral valve degeneration stage B1.B1期黏液瘤样二尖瓣退化犬抗氧化状态和脂质过氧化的评估。
Front Vet Sci. 2023 Sep 6;10:1203480. doi: 10.3389/fvets.2023.1203480. eCollection 2023.

本文引用的文献

1
Peripheral blood lymphocyte subtypes in dogs with different stages of myxomatous mitral valve disease.不同阶段黏液瘤性二尖瓣疾病犬的外周血淋巴细胞亚群。
J Vet Intern Med. 2021 Sep;35(5):2112-2122. doi: 10.1111/jvim.16207. Epub 2021 Jul 8.
2
Coenzyme Q10 and Immune Function: An Overview.辅酶Q10与免疫功能:概述
Antioxidants (Basel). 2021 May 11;10(5):759. doi: 10.3390/antiox10050759.
3
Inflammation and its association with oxidative stress in dogs with heart failure.心力衰竭犬的炎症及其与氧化应激的关系。
BMC Vet Res. 2021 Apr 26;17(1):176. doi: 10.1186/s12917-021-02878-x.
4
Randomized, double-blinded, controlled trial of the effects of coenzyme Q supplementation on plasma coenzyme Q concentration in dogs with myxomatous mitral valve disease.随机、双盲、对照试验研究辅酶 Q 补充对黏液样二尖瓣病变犬血浆辅酶 Q 浓度的影响。
Am J Vet Res. 2021 Apr;82(4):280-285. doi: 10.2460/ajvr.82.4.280.
5
Depleted Myocardial Coenzyme Q10 in Cavalier King Charles Spaniels with Congestive Heart Failure Due to Myxomatous Mitral Valve Disease.患有黏液瘤性二尖瓣疾病所致充血性心力衰竭的查理士王小猎犬心肌辅酶Q10水平降低。
Antioxidants (Basel). 2021 Jan 22;10(2):161. doi: 10.3390/antiox10020161.
6
Isoprostanes in Veterinary Medicine: Beyond a Biomarker.兽医学中的异前列腺素:超越生物标志物
Antioxidants (Basel). 2021 Jan 20;10(2):145. doi: 10.3390/antiox10020145.
7
The Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases.氧化应激在心血管衰老和心血管疾病中的作用
Life (Basel). 2021 Jan 15;11(1):60. doi: 10.3390/life11010060.
8
Oxidative Stress and Antioxidant Treatments in Cardiovascular Diseases.心血管疾病中的氧化应激与抗氧化治疗
Antioxidants (Basel). 2020 Dec 17;9(12):1292. doi: 10.3390/antiox9121292.
9
Changes of inflammatory and oxidative stress biomarkers in dogs with different stages of heart failure.不同心力衰竭阶段犬的炎症和氧化应激生物标志物的变化。
BMC Vet Res. 2020 Nov 10;16(1):433. doi: 10.1186/s12917-020-02650-7.
10
Low coenzyme Q10 levels in patients with acute cardiovascular disease are associated with long-term mortality.急性心血管病患者辅酶 Q10 水平低与长期死亡率相关。
Heart Vessels. 2021 Mar;36(3):401-407. doi: 10.1007/s00380-020-01698-7. Epub 2020 Sep 16.